品牌现货直购
供应商:我要出现这里






查看所有供应商和价格请点击:

1836-75-5生产厂家

1836-75-5价格

1836-75-5

1836-75-5结构式
1836-75-5结构式
  • 常用中文名:除草醚
  • 常用英文名:nitrofen
  • CAS号:1836-75-5
  • 分子式:C12H7Cl2NO3
  • 分子量:284.095
  • 相关类别: 化学农药原药 除草剂 二苯醚类除草剂
  • 发布时间:2018-02-05 08:00:00
  • 更新时间:2024-01-06 12:52:32
  • Nitrofen 是一种选择性接触除草剂,也是一种视网膜脱氢酶 (retinal dehydrogenase) 和原卟啉原氧化酶 (protoporphyrinogen oxidase) 抑制剂。

化源商城直购

中文名 除草醚
英文名 nitrofen
中文别名 2,4-二氯苯基-4'-硝基苯基醚
2,4-二氯-4'-硝基联苯醚
4-2,4-二氯苯氧基硝基苯
硝基酚酸
2,4-二氯-4'-硝基二苯醚
4-(2,4-二氯苯氧基)硝基苯
2,4-二氯-4-硝基联苯醚
英文别名 niclofen
Benzene, 2,4-dichloro-1-(4-nitrophenoxy)-
nitrofen
4-Nitro-2',4'-dichlorodiphenyl ether
Trizilin
2,4-dichlorophenyl-4-nitrophenyl ether
2,4-Dichloro-4'-nitrobiphenyl Ether
2,4-Dichloro-1-(4-nitrophenoxy)benzene
2,4-Dichlorophenyl 4-nitrophenyl ether
MFCD00128026
NIP
Mezotox
2,4-Dichloro-4'-nitrodiphenyl ether
Nitrophen
Nitrafen
EINECS 217-406-0
Nitrochlor
Tokkorn
WNR DOR BG DG
密度 1.5±0.1 g/cm3
沸点 360.6±32.0 °C at 760 mmHg
熔点 69-70°C
分子式 C12H7Cl2NO3
分子量 284.095
闪点 171.9±25.1 °C
精确质量 282.980286
PSA 55.05000
LogP 4.92
外观性状 无色至棕色结晶粉末,暴露在光下会变暗
蒸汽压 0.0±0.8 mmHg at 25°C
折射率 1.623
储存条件

密封、在 0-6 ºC下保存

稳定性

如果遵照规格使用和储存则不会分解,未有已知危险反应

水溶解性 可溶于:甲醇
计算化学

1.疏水参数计算参考值(XlogP):无

2.氢键供体数量:0

3.氢键受体数量:3

4.可旋转化学键数量:2

5.互变异构体数量:无

6.拓扑分子极性表面积55

7.重原子数量:18

8.表面电荷:0

9.复杂度:290

10.同位素原子数量:0

11.确定原子立构中心数量:0

12.不确定原子立构中心数量:0

13.确定化学键立构中心数量:0

14.不确定化学键立构中心数量:0

15.共价键单元数量:1

更多

1. 性状:晶体

2. 密度(g/mL,25ºC):未确定

3. 相对蒸汽密度(g/mL,空气=1): 未确定

4. 熔点(ºC):68-71

5. 沸点(ºC):未确定

6. 沸点(ºC,0.4mmHg):未确定

7. 折射率:未确定

8. 闪点(°C):未确定

9. 比旋光度(ºC):未确定

10. 自燃点或引燃温度(ºC):未确定

11. 蒸气压(kPa,25ºC):未确定

12. 饱和蒸气压(kPa,60ºC):未确定

13. 燃烧热(KJ/mol):未确定

14. 临界温度(ºC):未确定

15. 临界压力(KPa):未确定

16. 油水(辛醇/水)分配系数的对数值:未确定

17. 爆炸上限(%,V/V):未确定

18. 爆炸下限(%,V/V):未确定

19. 溶解性:不能溶解的

第一部分:化学品名称
化学品中文名称: 除草醚;2,4-二氯-1-(4-硝基苯氧基)苯
化学品英文名称: Nitrofcn;2,4-Dichloro-1-(4-nitrophenoxy)benzene
中文俗名或商品名:
Synonyms:
CAS No.: 1836-75-5
分子式: C12H7Cl2NO3
分子量: 284.1
第二部分:成分/组成信息
纯化学品混合物
化学品名称:除草醚;2,4-二氯-1-(4-硝基苯氧基)苯
有害物成分 含量 CAS No.
除草醚 1836-75-5
第三部分:危险性概述
危险性类别: 第6.1类毒害品
侵入途径: 吸入 食入 经皮吸收
健康危害: 本品为低毒除草剂。吸入、摄入或经皮肤吸收后中毒。对眼睛和皮肤有刺激作用。资料报道有致突变作用。受热分解放出氯和氮氧化物。
环境危害:
燃爆危险: 本品可燃,具刺激性。
第四部分:急救措施
皮肤接触: 用肥皂水及清水彻底冲洗。就医。
眼睛接触: 拉开眼睑,用流动清水冲洗15分钟。就医。
吸入: 迅速脱离现场至空气新鲜处。保持呼吸道通畅。如呼吸困难,给输氧。如呼吸停止,立即进行人工呼吸。就医。
食入: 误服者,饮适量温水,催吐。就医。
第五部分:消防措施
危险特性: 遇明火、高热可燃。其粉体与空气可形成爆炸性混合物, 当达到一定浓度时, 遇火星会发生爆炸。受高热分解放出有毒的气体。
有害燃烧产物: 一氧化碳、二氧化碳、氮氧化物、氯化氢。
灭火方法及灭火剂: 泡沫、干粉、砂土。
消防员的个体防护: 消防人员须戴好防毒面具,在安全距离以外,在上风向灭火。
禁止使用的灭火剂:
闪点(℃):
自燃温度(℃):
爆炸下限[%(V/V)]:
爆炸上限[%(V/V)]:
最小点火能(mJ):
爆燃点:
爆速:
最大燃爆压力(MPa):
建规火险分级:
第六部分:泄漏应急处理
应急处理: 隔离泄漏污染区,周围设警告标志,建议应急处理人员戴好防毒面具,穿化学防护服。用砂土或其它不燃性吸附剂混合吸收,然后收集运至废物处理场所。也可以用大量水冲洗,经稀释的洗水放入废水系统。如大量泄漏,收集回收或无害处理后废弃。
第七部分:操作处置与储存
操作注意事项: 密闭操作,提供充分的局部排风。防止粉尘释放到车间空气中。操作人员必须经过专门培训,严格遵守操作规程。建议操作人员佩戴防尘面具(全面罩),穿防毒物渗透工作服,戴橡胶手套。远离火种、热源,工作场所严禁吸烟。使用防爆型的通风系统和设备。避免产生粉尘。避免与氧化剂接触。配备相应品种和数量的消防器材及泄漏应急处理设备。倒空的容器可能残留有害物。
储存注意事项: 储存于阴凉、通风的库房。远离火种、热源。防止阳光直射。包装密封。应与氧化剂分开存放,切忌混储。配备相应品种和数量的消防器材。储区应备有合适的材料收容泄漏物。
第八部分:接触控制/个体防护
最高容许浓度: 中 国 MAC:未制订标准前苏联 MAC:未制订标准美国TLV—TWA:未制订标准
监测方法:
工程控制: 生产过程密闭,加强通风。
呼吸系统防护: 可能接触其粉尘时,必须佩戴防尘面具(全面罩)。紧急事态抢救或撤离时,应该佩戴空气呼吸器。
眼睛防护: 呼吸系统防护中已作防护。
身体防护: 穿防毒物渗透工作服。
手防护: 戴橡胶手套。
其他防护: 工作现场禁止吸烟、进食和饮水。工作后,淋浴更衣。保持良好的卫生习惯。
第九部分:理化特性
外观与性状: 纯品为淡黄色针状结晶,原药为黄色至褐色片状或块状固体。
pH:
熔点(℃): 70-71
沸点(℃):
相对密度(水=1):
相对蒸气密度(空气=1):
饱和蒸气压(kPa): 1.06X10-6/40℃
燃烧热(kJ/mol):
临界温度(℃):
临界压力(MPa):
辛醇/水分配系数的对数值:
闪点(℃):
引燃温度(℃):
爆炸上限%(V/V):
爆炸下限%(V/V):
分子式: C12H7Cl2NO3
分子量: 284.1
蒸发速率:
粘性:
溶解性: 微溶于水,易溶于甲醇、乙醇、丙酮、苯。
主要用途: 农用除草剂。
第十部分:稳定性和反应活性
稳定性: 在常温常压下 稳定
禁配物: 强氧化剂。
避免接触的条件:
聚合危害: 不能出现
分解产物: 一氧化碳、二氧化碳、氯化氢、氮氧化物。
第十一部分:毒理学资料
急性毒性: LD50:1894mg/kg(大鼠经口);5000mg/kg(大鼠经皮) LC50:
急性中毒:
慢性中毒:
亚急性和慢性毒性:
刺激性:
致敏性:
致突变性:
致畸性:
致癌性:
第十二部分:生态学资料
生态毒理毒性:
生物降解性:
非生物降解性:
生物富集或生物积累性:
第十三部分:废弃处置
废弃物性质:
废弃处置方法: 建议用焚烧法处置。在能利用的地方重复使用容器或在规定场所掩埋。
废弃注意事项:
第十四部分:运输信息
危险货物编号: 61904
UN编号: 2588
包装标志:
包装类别:
包装方法: 塑料袋或二层牛皮纸袋外全开口或中开口钢桶;两层塑料袋或一层塑料袋外麻袋、塑料编织袋、乳胶布袋;塑料袋外复合塑料编织袋(聚丙烯三合一袋、聚乙烯三合一袋、聚丙烯二合一袋、聚乙烯二合一袋);塑料袋或二层牛皮纸袋外普通木箱;螺纹口玻璃瓶、塑料瓶、复合塑料瓶或铝瓶外普通木箱;塑料瓶、两层塑料袋或两层牛皮纸袋(内或外套以塑料袋)外瓦楞纸箱。
运输注意事项: 铁路运输时包装所用的麻袋、塑料编织袋、复合塑料编织袋的强度应符合国家标准要求。运输前应先检查包装容器是否完整、密封,运输过程中要确保容器不泄漏、不倒塌、不坠落、不损坏。严禁与酸类、氧化剂、食品及食品添加剂混运。运输时运输车辆应配备相应品种和数量的消防器材及泄漏应急处理设备。运输途中应防曝晒、雨淋,防高温。公路运输时要按规定路线行驶,勿在居民区和人口稠密区停留。
RETCS号:
IMDG规则页码:
第十五部分:法规信息
国内化学品安全管理法规: 化学危险物品安全管理条例 (1987年2月17日国务院发布),化学危险物品安全管理条例实施细则 (化劳发[1992] 677号),工作场所安全使用化学品规定 ([1996]劳部发423号)等法规,针对化学危险品的安全使用、生产、储存、运输、装卸等方面均作了相应规定;常用危险化学品的分类及标志 (GB 13690-92)将该物质划为第6.1 类毒害品。
国际化学品安全管理法规:
第十六部分:其他信息
参考文献: 1.周国泰,化学危险品安全技术全书,化学工业出版社,1997 2.国家环保局有毒化学品管理办公室、北京化工研究院合编,化学品毒性法规环境数据手册,中国环境科学出版社.1992 3.Canadian Centre for Occupational Health and Safety,CHEMINFO Database.1998 4.Canadian Centre for Occupational Health and Safety, RTECS Database, 1989
填表时间: 年月日
填表部门:
数据审核单位:
修改说明:
其他信息: 5
MSDS修改日期: 年月日

生态学数据:

对水是极其危害的,即使是少量产品渗入地下也会对饮用水造成危害,若无政府许可勿将产品排入周围环境。对水中有机物有危害

CHEMICAL IDENTIFICATION

RTECS NUMBER :
KN8400000
CHEMICAL NAME :
Ether, 2,4-dichlorophenyl p-nitrophenyl
CAS REGISTRY NUMBER :
1836-75-5
BEILSTEIN REFERENCE NO. :
1887356
LAST UPDATED :
199710
DATA ITEMS CITED :
64
MOLECULAR FORMULA :
C12-H7-Cl2-N-O3
MOLECULAR WEIGHT :
284.10
WISWESSER LINE NOTATION :
WNR DOR BG DG

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
740 mg/kg
TOXIC EFFECTS :
Behavioral - excitement Lungs, Thorax, or Respiration - respiratory stimulation Nutritional and Gross Metabolic - body temperature increase
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Administration onto the skin
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
5 gm/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Unreported
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
3 gm/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
450 mg/kg
TOXIC EFFECTS :
Behavioral - excitement Lungs, Thorax, or Respiration - respiratory stimulation Nutritional and Gross Metabolic - body temperature increase
TYPE OF TEST :
LDLo - Lowest published lethal dose
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Mammal - cat
DOSE/DURATION :
300 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
TYPE OF TEST :
LCLo - Lowest published lethal concentration
ROUTE OF EXPOSURE :
Inhalation
SPECIES OBSERVED :
Mammal - cat
DOSE/DURATION :
620 mg/m3/4H
TOXIC EFFECTS :
Behavioral - excitement Lungs, Thorax, or Respiration - dyspnea Gastrointestinal - changes in structure or function of salivary glands
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - rabbit
DOSE/DURATION :
1620 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
TYPE OF TEST :
LDLo - Lowest published lethal dose
ROUTE OF EXPOSURE :
Administration onto the skin
SPECIES OBSERVED :
Rodent - rabbit
DOSE/DURATION :
3270 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
13650 mg/kg/13W-C
TOXIC EFFECTS :
Liver - changes in liver weight Kidney, Ureter, Bladder - changes in bladder weight Related to Chronic Data - changes in testicular weight
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
40740 mg/kg/13W-C
TOXIC EFFECTS :
Liver - changes in liver weight Kidney, Ureter, Bladder - changes in bladder weight
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
40740 mg/kg/97W-C
TOXIC EFFECTS :
Liver - changes in liver weight Kidney, Ureter, Bladder - changes in bladder weight Related to Chronic Data - death
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Mammal - dog
DOSE/DURATION :
1400 mg/kg/4W-C
TOXIC EFFECTS :
Liver - changes in liver weight
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Mammal - dog
DOSE/DURATION :
36400 mg/kg/2Y-C
TOXIC EFFECTS :
Liver - changes in liver weight
TYPE OF TEST :
TCLo - Lowest published toxic concentration
ROUTE OF EXPOSURE :
Inhalation
SPECIES OBSERVED :
Mammal - cat
DOSE/DURATION :
26 mg/m3/4H/7W-I
TOXIC EFFECTS :
Blood - pigmented or nucleated red blood cells Biochemical - Enzyme inhibition, induction, or change in blood or tissue levels - catalases Related to Chronic Data - death
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
42 gm/kg/94W-C
TOXIC EFFECTS :
Tumorigenic - Carcinogenic by RTECS criteria Vascular - tumors Liver - tumors
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
24 gm/kg/12W-C
TOXIC EFFECTS :
Tumorigenic - Carcinogenic by RTECS criteria Liver - tumors Lungs, Thorax, or Respiration - tumors
TYPE OF TEST :
TD - Toxic dose (other than lowest)
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
200 gm/kg/78W-C
TOXIC EFFECTS :
Tumorigenic - Carcinogenic by RTECS criteria Vascular - tumors Liver - tumors
TYPE OF TEST :
TD - Toxic dose (other than lowest)
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
308 gm/kg/78W-C
TOXIC EFFECTS :
Tumorigenic - Carcinogenic by RTECS criteria Vascular - tumors Liver - tumors
TYPE OF TEST :
TD - Toxic dose (other than lowest)
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
114 gm/kg/58W-C
TOXIC EFFECTS :
Tumorigenic - Carcinogenic by RTECS criteria Vascular - tumors Liver - tumors
TYPE OF TEST :
TD - Toxic dose (other than lowest)
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
47 gm/kg/12W-C
TOXIC EFFECTS :
Tumorigenic - Carcinogenic by RTECS criteria Liver - tumors Lungs, Thorax, or Respiration - tumors
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
DOSE :
62500 ug/kg
SEX/DURATION :
female 6-15 day(s) after conception
TOXIC EFFECTS :
Reproductive - Specific Developmental Abnormalities - body wall Reproductive - Specific Developmental Abnormalities - respiratory system Reproductive - Specific Developmental Abnormalities - urogenital system
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
DOSE :
150 mg/kg
SEX/DURATION :
female 7-12 day(s) after conception
TOXIC EFFECTS :
Reproductive - Effects on Embryo or Fetus - cytological changes (including somatic cell genetic material)
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
DOSE :
37530 ug/kg
SEX/DURATION :
female 6-18 day(s) after conception
TOXIC EFFECTS :
Reproductive - Effects on Newborn - physical
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
DOSE :
62500 ug/kg
SEX/DURATION :
female 6-15 day(s) after conception
TOXIC EFFECTS :
Reproductive - Effects on Embryo or Fetus - fetotoxicity (except death, e.g., stunted fetus)
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
DOSE :
100 mg/kg
SEX/DURATION :
female 11 day(s) after conception
TOXIC EFFECTS :
Reproductive - Effects on Newborn - growth statistics (e.g.%, reduced weight gain)
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
DOSE :
80 mg/kg
SEX/DURATION :
female 10-13 day(s) after conception
TOXIC EFFECTS :
Reproductive - Specific Developmental Abnormalities - cardiovascular (circulatory) system Reproductive - Effects on Newborn - stillbirth Reproductive - Effects on Newborn - viability index (e.g., # alive at day 4 per # born alive)
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Administration onto the skin
DOSE :
12 mg/kg
SEX/DURATION :
female 6-15 day(s) after conception
TOXIC EFFECTS :
Reproductive - Specific Developmental Abnormalities - eye/ear Reproductive - Specific Developmental Abnormalities - respiratory system
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Administration onto the skin
DOSE :
120 mg/kg
SEX/DURATION :
female 6-15 day(s) after conception
TOXIC EFFECTS :
Reproductive - Specific Developmental Abnormalities - body wall Reproductive - Specific Developmental Abnormalities - endocrine system Reproductive - Specific Developmental Abnormalities - urogenital system
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Administration onto the skin
DOSE :
120 mg/kg
SEX/DURATION :
female 6-15 day(s) after conception
TOXIC EFFECTS :
Reproductive - Effects on Newborn - viability index (e.g., # alive at day 4 per # born alive) Reproductive - Effects on Newborn - growth statistics (e.g.%, reduced weight gain)
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Unreported
DOSE :
13900 ug/kg
SEX/DURATION :
female 7-16 day(s) after conception
TOXIC EFFECTS :
Reproductive - Specific Developmental Abnormalities - body wall
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Unreported
DOSE :
125 mg/kg
SEX/DURATION :
female 7-16 day(s) after conception
TOXIC EFFECTS :
Reproductive - Specific Developmental Abnormalities - eye/ear
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Unreported
DOSE :
220 mg/kg
SEX/DURATION :
female 8-18 day(s) after conception
TOXIC EFFECTS :
Reproductive - Specific Developmental Abnormalities - respiratory system
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Unreported
DOSE :
352 mg/kg
SEX/DURATION :
female 8-18 day(s) after conception
TOXIC EFFECTS :
Reproductive - Effects on Newborn - viability index (e.g., # alive at day 4 per # born alive)
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
DOSE :
660 mg/kg
SEX/DURATION :
female 5-15 day(s) after conception
TOXIC EFFECTS :
Reproductive - Specific Developmental Abnormalities - respiratory system Reproductive - Effects on Newborn - weaning or lactation index (e.g., # alive at weaning per # alive at day 4)
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
DOSE :
1100 mg/kg
SEX/DURATION :
female 7-17 day(s) after conception
TOXIC EFFECTS :
Reproductive - Effects on Newborn - viability index (e.g., # alive at day 4 per # born alive) Reproductive - Effects on Newborn - physical Reproductive - Effects on Newborn - delayed effects
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
DOSE :
660 mg/kg
SEX/DURATION :
female 5-15 day(s) after conception
TOXIC EFFECTS :
Reproductive - Effects on Embryo or Fetus - fetotoxicity (except death, e.g., stunted fetus) Reproductive - Effects on Newborn - physical
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
DOSE :
68750 ug/kg
SEX/DURATION :
female 7-17 day(s) after conception
TOXIC EFFECTS :
Reproductive - Specific Developmental Abnormalities - other developmental abnormalities Reproductive - Effects on Newborn - physical
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
DOSE :
550 mg/kg
SEX/DURATION :
female 7-17 day(s) after conception
TOXIC EFFECTS :
Reproductive - Effects on Newborn - viability index (e.g., # alive at day 4 per # born alive)
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
DOSE :
2520 mg/kg
SEX/DURATION :
female 1-21 day(s) after conception
TOXIC EFFECTS :
Reproductive - Specific Developmental Abnormalities - body wall Reproductive - Specific Developmental Abnormalities - respiratory system Reproductive - Specific Developmental Abnormalities - hepatobiliary system
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Administration onto the skin
DOSE :
175 mg/kg
SEX/DURATION :
female 8 day(s) after conception
TOXIC EFFECTS :
Reproductive - Effects on Newborn - other neonatal measures or effects
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Administration onto the skin
DOSE :
160 mg/kg
SEX/DURATION :
female 8 day(s) after conception
TOXIC EFFECTS :
Reproductive - Effects on Newborn - viability index (e.g., # alive at day 4 per # born alive)
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Administration onto the skin
DOSE :
286 mg/kg
SEX/DURATION :
female 8 day(s) after conception
TOXIC EFFECTS :
Reproductive - Specific Developmental Abnormalities - endocrine system
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Administration onto the skin
DOSE :
1100 mg/kg
SEX/DURATION :
female 7-17 day(s) after conception
TOXIC EFFECTS :
Reproductive - Effects on Newborn - viability index (e.g., # alive at day 4 per # born alive)
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Unreported
DOSE :
550 mg/kg
SEX/DURATION :
female 7-17 day(s) after conception
TOXIC EFFECTS :
Reproductive - Specific Developmental Abnormalities - eye/ear
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Unreported
DOSE :
1100 mg/kg
SEX/DURATION :
female 7-17 day(s) after conception
TOXIC EFFECTS :
Reproductive - Effects on Newborn - viability index (e.g., # alive at day 4 per # born alive)
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Unreported
DOSE :
500 mg/kg
SEX/DURATION :
female 7-11 day(s) after conception
TOXIC EFFECTS :
Reproductive - Specific Developmental Abnormalities - eye/ear Reproductive - Specific Developmental Abnormalities - urogenital system

MUTATION DATA

TYPE OF TEST :
Morphological transformation
TEST SYSTEM :
Rodent - rat Embryo
DOSE/DURATION :
1500 ng/plate
REFERENCE :
JJATDK JAT, Journal of Applied Toxicology. (John Wiley & Sons Ltd., Baffins Lane, Chichester, W. Sussex PO19 1UD, UK) V.1- 1981- Volume(issue)/page/year: 1,190,1981 *** REVIEWS *** IARC Cancer Review:Animal Sufficient Evidence IMEMDT IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- Volume(issue)/page/year: 30,271,1983 IARC Cancer Review:Human No Adequate Data IMEMDT IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- Volume(issue)/page/year: 30,271,1983 IARC Cancer Review:Group 2B IMSUDL IARC Monographs, Supplement. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) No.1- 1979- Volume(issue)/page/year: 7,56,1987 TOXICOLOGY REVIEW APLMAS Archives of Pathology and Laboratory Medicine. (AMA, 535 N. Dearborn St., Chicago, IL 60610) V.1-5(2), 1926-28; V.100- 1976- Volume(issue)/page/year: 107,54,1983 *** OCCUPATIONAL EXPOSURE LIMITS *** OEL-FINLAND;Carcinogen JAN 1993 OEL-RUSSIA:STEL 1 mg/m3 JAN 1993

符号 GHS07 GHS08 GHS09
GHS07, GHS08, GHS09
信号词 Danger
危害声明 H302-H350-H360D-H410
警示性声明 P201-P273-P308 + P313-P501
个人防护装备 Eyeshields;full-face particle respirator type N100 (US);Gloves;respirator cartridge type N100 (US);type P1 (EN143) respirator filter;type P3 (EN 143) respirator cartridges
危害码 (欧洲) T:Toxic;N:Dangerousfortheenvironment;
风险声明 (欧洲) R22;R45;R50/53;R61
安全声明 (欧洲) 45-53-61-60
危险品运输编码 3077
WGK德国 3
RTECS号 KN8400000
海关编码 2909309011

~%

1836-75-5结构式

1836-75-5

文献:Collection of Czechoslovak Chemical Communications, , vol. 74, # 11-12 p. 1647 - 1664

~67%

1836-75-5结构式

1836-75-5

文献:Khalilzadeh, Mohammad A.; Hosseini, Abolfazl; Pilevar, Afsaneh European Journal of Organic Chemistry, 2011 , # 8 p. 1587 - 1592

~90%

1836-75-5结构式

1836-75-5

文献:Khalilzadeh, Mohammad A.; Hosseini, Abolfazl; Pilevar, Afsaneh European Journal of Organic Chemistry, 2011 , # 8 p. 1587 - 1592

~%

1836-75-5结构式

1836-75-5

文献:US4301295 A1, ;

~%

1836-75-5结构式

1836-75-5

文献:Journal of the American Chemical Society, , vol. 52, p. 1205,1207

由2,4-二氯酚与对硝基氯苯在氢氧化钾(或氢氧化钠)存在下直接缩合而得

海关编码 2909309011
中文概述 2909309011 甲氧滴滴涕、除草醚。监管条件:S(进出口农药登记证明)。增值税率:17.0%。退税率:0.0%。最低关税:5.5%。普通关税:30.0%
申报要素 品名, 成分含量, 用途
监管条件 S.进出口农药登记证明
Summary 2909309011 4,4'-(2,2,2-trichloroethane-1,1-diyl)bis(methoxybenzene)。supervision conditions:s(import or export registration certificate for pesticides)。VAT:17.0%。tax rebate rate:0.0%。MFN tarrif:5.5%。general tariff:30.0%